CD20+ B cells: the other tumor-infiltrating lymphocytes.
about
Positive and negative functions of B lymphocytes in tumorsLactate Contribution to the Tumor Microenvironment: Mechanisms, Effects on Immune Cells and Therapeutic RelevanceThe immunological effect of hyaluronan in tumor angiogenesisMedulloblastoma-biology and microenvironment: a reviewEmerging roles of T helper 17 and regulatory T cells in lung cancer progression and metastasisVaccination with Melanoma Helper Peptides Induces Antibody Responses Associated with Improved Overall Survival.Human solid tumor xenografts in immunodeficient mice are vulnerable to lymphomagenesis associated with Epstein-Barr virus.Predictive Value of Tertiary Lymphoid Structures Assessed by High Endothelial Venule Counts in the Neoadjuvant Setting of Triple-Negative Breast Cancer.B cells regulate macrophage phenotype and response to chemotherapy in squamous carcinomas.Characterization of tumor-associated B-cell subsets in patients with colorectal cancer.Characterisation and prognostic value of tertiary lymphoid structures in oral squamous cell carcinomaEx-vivo clonally expanded B lymphocytes infiltrating colorectal carcinoma are of mature immunophenotype and produce functional IgG.Modeling putative therapeutic implications of exosome exchange between tumor and immune cells.Relationships between tumor microenvironment and clinicopathological parameters in meningiomaPrognostic significance of B-cells and pSTAT3 in patients with ovarian cancer.Multiplexed quantitative analysis of CD3, CD8, and CD20 predicts response to neoadjuvant chemotherapy in breast cancer.Prognostic value of immune cell infiltration, tertiary lymphoid structures and PD-L1 expression in Merkel cell carcinomas.B cells promote tumor progression via STAT3 regulated-angiogenesisProspective validation of immunological infiltrate for prediction of response to neoadjuvant chemotherapy in HER2-negative breast cancer--a substudy of the neoadjuvant GeparQuinto trial.Adoptive transfer of tumor reactive B cells confers host T-cell immunity and tumor regressionTertiary lymphoid structures are associated with higher tumor grade in primary operable breast cancer patients.A distinct pre-existing inflammatory tumour microenvironment is associated with chemotherapy resistance in high-grade serous epithelial ovarian cancer.Leukocyte composition of human breast cancerAbsolute lymphocyte count is associated with survival in ovarian cancer independent of tumor-infiltrating lymphocytesTargeting CD20 in melanoma patients at high risk of disease recurrence.A Lower Proportion of Regulatory B Cells in Patients with Henoch-Schoenlein Purpura NephritisOverrepresentation of IL-10-Expressing B Cells Suppresses Cytotoxic CD4+ T Cell Activity in HBV-Induced Hepatocellular CarcinomaThe skin, a novel niche for recirculating B cells.Intratumoral tertiary lymphoid organ is a favourable prognosticator in patients with pancreatic cancer.Th2 type inflammation promotes the gradual progression of HPV-infected cervical cells to cervical carcinoma.Integrative analysis of breast cancer reveals prognostic haematopoietic activity and patient-specific immune response profilesTumor-infiltrating B cells come into vogueCD19+CD24hiCD38hiBregs involved in downregulate helper T cells and upregulate regulatory T cells in gastric cancer.Distribution and significance of interstitial fibrosis and stroma-infiltrating B cells in tongue squamous cell carcinomaPD-1 Blockade Expands Intratumoral Memory T Cells.Spatial distribution of B cells predicts prognosis in human pancreatic adenocarcinoma.CD4⁺ follicular helper T cell infiltration predicts breast cancer survivalImmunotherapy: shifting the balance of cell-mediated immunity and suppression in human prostate cancer.Epithelial cell-adhesion molecule-directed trifunctional antibody immunotherapy for symptom management of advanced ovarian cancer.Collaboration between tumor-specific CD4+ T cells and B cells in anti-cancer immunity.
P2860
Q26743398-15E7CBCF-925B-4EC2-B9CC-025F78367F38Q26766711-BD9A8AA6-1FE4-42D7-BF19-70AF1EDA18C5Q26771483-13EF0B63-453B-4004-BA24-A21C9AA35CA6Q26995823-B1495A96-217D-4A58-B363-CE87764A4750Q28069422-CC2EDC56-3D10-4837-8663-9DC18070CBB0Q30299957-246BA041-D1FC-4918-9B5B-20E8A0F7EEAAQ31068871-65960C2F-5E6D-4F39-AF69-9DBA4477DA12Q33584033-DFA666E6-B9FC-4A78-AA6A-68AF5C849FF8Q33776937-35699B23-65D4-4B89-8C8E-947A3B9F0CEBQ34103969-44E69B22-DA83-4346-8467-FBB7F09C4CD2Q34105741-722100CB-E6C4-45B7-8CFE-FDF2E3396C3AQ34185964-0EF160F5-5C74-486D-B56D-13807F43428CQ34407541-1FBA6F86-91EC-4613-92E6-A5B245280C7AQ34501928-E5FB3394-8839-415B-B4FB-180681E1C68FQ34552079-D803814A-2B56-4B58-8741-11CB2E38C4EAQ34616067-45106630-A69A-4672-BADD-060B53C9B786Q34733445-0617F371-D853-4EAD-9895-7D265AFE44CDQ34755398-99CE841F-6E0A-4FB8-A331-94ACDC1CD5E6Q35060987-ACD2F3E2-889D-4C5E-8BCE-FED8FFD91045Q35146131-180133B2-03A2-4DAC-A379-5962A137AFDDQ35170144-9B34F87D-8AB4-4EF2-94AF-804679C5AA13Q35274995-1FE2A44A-F035-48D7-AEF5-0BCE403CCA11Q35779386-89716F04-46A8-41F9-867F-FB2E63D68BB0Q35847903-9FCC89EB-9AB4-4E1E-AB85-57B723F6B0C1Q35939451-404B0534-0836-4FBE-9C73-83479F7E5884Q35974823-2C35A3C5-157E-47A0-B01F-A33C10345C56Q36005233-ADCE660A-C0B8-4F68-A2EC-00FA442C3A03Q36016271-097765D7-D1BB-4C19-8B88-BDD6093603CCQ36285953-366FD3FC-B38F-4491-8BB8-3CFFCE2A0C10Q36319582-42C6BE75-CF51-40AD-8234-4C52C86C3E13Q36499105-9C77A2E8-CE48-4DDC-A967-C12D962EE522Q36525540-849D04AF-5E66-4B62-AE4D-CDF478A39173Q36545192-40D2420A-8C1A-4592-935F-50D049B506A8Q36640353-E9B6DBE7-7F9B-452D-8C50-387395451AC2Q36642804-4BA0E125-A931-419A-9B9A-93611F9A2C0EQ36821138-10E189D9-E418-48BF-B20F-16BE6C3C6F0AQ36966923-BD29F193-0BE0-474A-ADBA-1D66B9A089E7Q37017085-8A3E9C1B-C90D-4D62-977D-35C91F49351DQ37225693-0DA7ADB3-FE91-4943-9A62-54183E43D174Q37327460-2D74CB60-6CCC-47C0-85FC-D3F022601A3D
P2860
CD20+ B cells: the other tumor-infiltrating lymphocytes.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年学术文章
@wuu
2010年学术文章
@zh-cn
2010年学术文章
@zh-hans
2010年学术文章
@zh-my
2010年学术文章
@zh-sg
2010年學術文章
@yue
2010年學術文章
@zh
2010年學術文章
@zh-hant
name
CD20+ B cells: the other tumor-infiltrating lymphocytes.
@en
CD20+ B cells: the other tumor-infiltrating lymphocytes.
@nl
type
label
CD20+ B cells: the other tumor-infiltrating lymphocytes.
@en
CD20+ B cells: the other tumor-infiltrating lymphocytes.
@nl
prefLabel
CD20+ B cells: the other tumor-infiltrating lymphocytes.
@en
CD20+ B cells: the other tumor-infiltrating lymphocytes.
@nl
P356
P1476
CD20+ B cells: the other tumor-infiltrating lymphocytes.
@en
P304
P356
10.4049/JIMMUNOL.1001323
P407
P577
2010-11-01T00:00:00Z